C12N 2795/10133
Use of viral protein as therapeutic agent other than vaccine
Official title: Use of viral protein as therapeutic agent other than vaccine, e.g. apoptosis inducing or anti-inflammatory
C12N2795/10133 (Use of viral protein as therapeutic agent other than vaccine) appears on 6 US grants and 11 published applications in this corpus.
Search patents in C12N- Granted patents
- 6
- Published applications
- 11
- Assignees
- 8
- Inventors
- 27
- Latest grant
- 16 Jul 2024
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2014 | 0 | 1 |
| 2015 | 0 | 0 |
| 2016 | 0 | 0 |
| 2017 | 1 | 1 |
| 2018 | 1 | 0 |
| 2019 | 0 | 3 |
| 2020 | 0 | 0 |
| 2021 | 2 | 1 |
| 2022 | 0 | 3 |
| 2023 | 1 | 1 |
| 2024 | 1 | 0 |
| 2025 | 0 | 1 |
By publication year.
Recent patents
- Prokaryotic-eukaryotic hybrid viral vector for delivery of large cargos of genes and proteins into human cells16 Jul 2024US 12,037,597 B2The Catholic University of America
- Vibrio parahaemolyticus bacteriophage Vib-PAP-4 and use thereof in inhibiting proliferation of Vibrio parahaemoliticus bacteria20 Jun 2023US 11,679,137 B2Intron Biotechnology, Inc.
- Modified peptides2 Nov 2021US 11,161,883 B2Sasinapas Co., Ltd.
- Prokaryotic-eukaryotic hybrid viral vector for delivery of large cargos of genes and proteins into human cells26 Oct 2021US 11,155,835 B2The Catholic University of America
- Chimeric antibacterial polypeptides3 Apr 2018US 9,932,569 B2GangaGen, Inc.
- Bacteriophages for Protection from Ultraviolet Irradiation1 May 2025US 2025/0134802 A1The Board of Trustees of the Leland Stanford Junior University
- Engineered chimeric antimicrobial agents against gram-positive bacteria28 Dec 2023US 2023/0416719 A1Massachusetts Institute of Technology
- Bacteriophages for inhibiting bacteria16 Jun 2022US 2022/0184155 A1Regents of the University of Minnesota
- Modified peptides24 Mar 2022US 2022/0089657 A1Sasinapas Co., Ltd.
- Prokaryotic-eukaryotic hybrid viral vector for delivery of large cargos of genes and proteins into human cells13 Jan 2022US 2022/0010335 A1The Catholic University of America
Most cited
By later US patents